Latest filing published 29 Jul 2013 for ONYX PHARMACEUTICALS INC, €116k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lopez Antonio J. Grillo: trading record in brief
Lopez Antonio J. Grillo is a declared insider at 2 companies; the most frequent names are Onyx Pharmaceuticals Inc and MMRGlobal, Inc. Over a trading history stretching from 2 November 2007 to 1 October 2013, the count stands at 33 filings.
Both buying and selling appear: 1 purchase, against 13 sales worth €6.5M. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 7 share grants and 11 option exercises. Since January 2013: no purchases and 9 sales on the market.
The latest filing, published on 3 October 2013, reports a transaction of €194k in Onyx Pharmaceuticals Inc. The latest purchase dates back some time: it was published 6,943 days ago, on 6 November 2007. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lopez Antonio J. Grillo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$76.79Common StockSEC:0001179110-13-012261:0
- 2,000 shares@ US$130.50Common StockSEC:0001179110-13-012261:1
- 5,000 shares@ US$37.68Common StockSEC:0001179110-13-007076:0
- 5,000 shares@ US$101.28Common StockSEC:0001179110-13-007076:1
- 3,164 shares@ US$28.55Common StockSEC:0001179110-13-006723:0
- 5,000 shares@ US$35.18Common StockSEC:0001179110-13-006723:1
- 5,000 shares@ US$30.28Common StockSEC:0001179110-13-006723:2
- 13,164 shares@ US$98.77Common StockSEC:0001179110-13-006723:3
- 10,000 shares@ US$12.87Common StockSEC:0001179110-13-006723:4
- 10,000 shares@ US$39.84Common StockSEC:0001179110-13-006723:5
- 10,000 shares@ US$31.72Common StockSEC:0001179110-13-006723:6
- 30,000 shares@ US$95.83Common StockSEC:0001179110-13-006723:7
- 5,000 shares@ US$15.15Common StockSEC:0001179110-13-006445:0
- 10,000 shares@ US$32.77Common StockSEC:0001179110-13-006445:1
- 10,000 shares@ US$20.03Common StockSEC:0001179110-13-006445:2
- 2,000 shares@ US$89.00Common StockSEC:0001179110-13-006445:3
- 18,637 shares@ US$91.38Common StockSEC:0001179110-13-006445:4
- 4,363 shares@ US$92.36Common StockSEC:0001179110-13-006445:5
- 2,100 shares0Common StockSEC:0001179110-13-006117:0
- 7,265 shares@ US$82.25Common StockSEC:0001179110-12-017680:0
- 1,500 shares0Common StockSEC:0001209191-12-039422:0
- 3,000 shares0Common StockSEC:0001209191-12-021644:0
- 3,000 shares0Common StockSEC:0001209191-11-021312:0
- 1,000 shares0Common StockSEC:0001209191-10-031182:0
- 2,000 shares0Common StockSEC:0001209191-10-020373:0
25 of 30 declarations